IL-36, a member of the IL-1 superfamily, and its receptor ligands (IL-36R), are overexpressed in both animal colitis models and human IBD patients, exhibiting both pathogenic and protective roles depending on the context. Here, IL1A is linked to inflammatory bowel disease.